Parkinson’s disease therapeutics market report for 2027 – Companies, applications, products and more

1
Parkinsons disease therapeutics market trends
research and projections for 2021- 2027

• A research study conducted by Global Market
  Insights, Inc., suggests that Parkinsons disease
  therapeutics market is likely to exceed the 8
  billion mark by 2027, in terms of revenue.
• The Parkinsons disease therapeutics market
  expansion would be augmented by extensive
  investments in RD activities to uplift the
  development in the treatment of the disease.
  Reportedly, the Parkinsons Foundation in 2021
  invested nearly US3.5 million in 34 research
  programs to support the efforts of promising
  scientists in the field of Parkinsons disease
  (PD).
• The Parkinsons Disease Biomarkers Program (PDBP)
  funding endorse discovery projects to encourage
  the identification of developments and diagnostic
  biomarkers for the disease. Consequently, a
  substantial rise in funding towards RD programs
  for the development of novel therapies will
  propel the demand for Parkinsons therapeutics in
  the forthcoming years.

2017 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
2

• The Parkinsons disease therapeutics industry
  progression would further be augmented by the
  growing awareness among the population about the
  disease. Early diagnosis of the disease plays a
  key role in providing effective treatment to the
  affected patient. The lack of awareness and
  knowledge among people about Parkinsons disease
  has led to the commencement of numerous awareness
  programs.

• The dopamine agonists segment accounted for a
  considerable revenue share at nearly US694
  million in 2021. The medication is highly
  preferred in the treatment of Parkinsons disease
  owing to its resemblance to the effect of
  dopamine in the brain

• The adult patient segment of the Parkinsons
  disease therapeutics industry is expected to grow
  at 6.9 CAGR up to 2027. The segment expansion is
  majorly attributed to the growing vulnerability
  to idiopathic Parkinsons disease among the aging
  population base.

2017 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
3
Request for a Sample Copy of this Report _at_
https//www.gminsights.com/request-sample/detail/2
724
2017 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
4

• Regional Analysis

• The Brazil Parkinsons disease therapeutics
  industry was over US90 million in 2021. The
  regional industry progression is predominantly
  driven by robust economic expansion, substantial
  development in healthcare infrastructure, and
  rising incidences of Parkinsons disease in the
  country. Also, the presence of dynamic
  pharmacology and biotechnology research sector
  backed by the Brazilian government will provide
  exponential growth opportunities to the regional
  industry.

• Competitive Analysis

• Leading firms functioning in the Parkinsons
  disease therapeutics industry include Teva
  Pharmaceutical, Acadia Pharmaceuticals, AbbVie
  Inc., UCB, Amneal Pharmaceuticals, Roche, and
  Orion Corporation, among others.

Request for Customization _at_ https//www.gminsights
.com/roc/2724
2017 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
5
Latest Research Report On Parkinsons disease
therapeutics Market _at_ https//www.gminsights.com/i
ndustry-analysis/parkinsons-disease-therapeutics-m
arket
Request for sample of this research report_at_
https//www.gminsights.com/request-sample/detail/2
724
Request for customization https//www.gminsights.
com/roc/2724
2017 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
6
Stay In Touch You can visit us at
www.gminsights.com
Thank You!
2017 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
www.gminsights.com